Podcast: This Week in Managed Care—FDA Addresses Vaccine Dose Schedules and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Read more about the stories in this podcast:

What We're Reading: FDA Stands Fast on COVID-19 Vaccine Dosing; Haven Dissolves; Moderna Boosts Dose Supply

Mammography Screenings Dropped, Advanced Breast Cancer Cases Increased in First Months of COVID-19

FDA Grants Tiragolumab Breakthrough Therapy Designation for PD-L1–High NSCLC

Azacitidine Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML